Glaucoma, Parkinson's disease and neurodegeneration

被引:0
|
作者
Balci, Sevcan Yildiz [1 ]
Eraslan, Muhsin [2 ]
Temel, Ahmet [2 ]
机构
[1] Igdir Devlet Hastanesi, Oftalmol Klin, Igdir, Turkey
[2] Marmara Univ, Tip Fak Hastanesi, Oftalmol Anabilim Dali, Ust Kaynarca, Pendik, Turkey
来源
MARMARA MEDICAL JOURNAL | 2015年 / 28卷 / 01期
关键词
Irreversible vision loss; Neurodegenerative disorders; Neuroprotective therapy;
D O I
10.5472/MMJ.2015.03691.1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Glaucoma is a disease that causes irreversible vision loss characterized by progressive retinal ganglion cell (RGC) death. The mechanisms independent of intraocular pressure are also implicated in glaucomatous degeneration pathogenesis and numerous similarities exist between glaucoma and neurodegenerative diseases such as Alzheimer's and Parkinson's diseases. Although, there is a common pathway between glaucoma and neurodegenerative disorders, pathogenesis of the relationship between neurodegenerative disorders and glaucoma remains poorly undefined. Optical coherence tomography (OCT), non-invasively quantifies the thickness of the retinal nerve fiber layer (RNFL) which is effected due to RGC damage in glaucomatous patients. Recently, RNFL thickness measurements have been studied by using OCT in several neurodegenerative conditions, including Parkinson's disease. The RNFL is unique as a model of neurodegeneration where the changes in its structure is represented with axonal damage. RNFL thickness measurements are important in neurodegenerative disorders which are characterized with neuronal loss and have common pathogenesis with glaucoma. In this review, we emphasize the relationship between glaucoma, Parkinson's disease and neurodegeneration.
引用
收藏
页码:8 / 12
页数:5
相关论文
共 50 条
  • [1] The Role of Microgliain Retinal Neurodegeneration: Alzheimer's Disease, Parkinson,and Glaucoma
    Ramirez, Ana I.
    de Hoz, Rosa
    Salobrar-Garcia, Elena
    Salazar, Juan J.
    Rojas, Blanca
    Ajoy, Daniel
    Lopez-Cuenca, Ines
    Rojas, Pilar
    Trivino, Alberto
    Ramirez, Jose M.
    FRONTIERS IN AGING NEUROSCIENCE, 2017, 9
  • [2] Ageing, neurodegeneration and Parkinson's disease
    Hindle, John V.
    AGE AND AGEING, 2010, 39 (02) : 156 - 161
  • [3] Markers of Neurodegeneration in Parkinson’s Disease
    M. A. Nikitina
    V. M. Alifirova
    S. O. Borodina
    E. S. Koroleva
    Neurochemical Journal, 2023, 17 : 338 - 348
  • [4] Imaging neurodegeneration in Parkinson's disease
    Pavese, Nicola
    Brooks, David J.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2009, 1792 (07): : 722 - 729
  • [5] Inflammation and neurodegeneration in Parkinson's disease
    McGeer, PL
    McGeer, EG
    PARKINSONISM & RELATED DISORDERS, 2004, 10 : S3 - S7
  • [6] Markers of Neurodegeneration in Parkinson's Disease
    Nikitina, M. A.
    Alifirova, V. M.
    Borodina, S. O.
    Koroleva, E. S.
    NEUROCHEMICAL JOURNAL, 2023, 17 (03) : 338 - 348
  • [7] The Mechanisms of Neurodegeneration in Parkinson's Disease
    Petrlenicova, D.
    Gmitterova, K.
    Benetin, J.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2010, 73 (06) : 645 - 649
  • [8] Extranigral Neurodegeneration in Parkinson's Disease A Role for Calpain in Neurodegeneration
    Samantaray, Supriti
    Butler, Jonathan T.
    Ray, Swapan K.
    Banik, Naren L.
    DRUG ADDICTION: RESEARCH FRONTIERS AND TREATMENT ADVANCES, 2008, 1139 : 331 - 336
  • [9] Mechanisms of neurodegeneration in idiopathic Parkinson's disease
    Schulz, Joerg B.
    PARKINSONISM & RELATED DISORDERS, 2007, 13 : S306 - S308
  • [10] Dysphagia and dopaminergic neurodegeneration in Parkinson's Disease
    Polychronis, S.
    Ribba, B.
    Nasios, G.
    Dardiotis, E.
    Pagano, G.
    MOVEMENT DISORDERS, 2023, 38 : S566 - S566